monstermisfitsgame.com → best get → cell phone best → what cell does hiv infect
Posted on by Nicholas Peterson

What Cell Does HIV Infect

Microscopic view of HIV particles attaching to a CD4 cell surface

HIV infects CD4 cells, a subset of T lymphocytes that coordinate the immune response. These cells are essential for activating other immune cells during infection.

CD4 cells express the CD4 protein on their surface, which acts as a receptor for HIV's envelope glycoprotein gp120. When HIV binds to CD4, it fuses with the cell membrane and releases its genetic material into the host cell. Once inside, HIV uses the cell's machinery to replicate, producing new virus particles that burst out and infect neighboring CD4 cells.

The loss of CD4 cells directly impairs the body's ability to fight infections. As HIV progresses, CD4 counts drop below 200 cells per microliter of blood-a threshold that defines AIDS. Without treatment, opportunistic infections such as Pneumocystis pneumonia or tuberculosis become life-threatening.

How HIV Targets CD4 Cells

HIV's specificity for CD4 cells stems from structural compatibility between gp120 and the CD4 receptor. The virus also requires a co-receptor-either CCR5 or CXCR4-to enter the cell. CCR5 is predominantly used during early infection, while CXCR4 becomes more common in later stages.

Some individuals carry a mutation called CCR5-Δ32, which deletes part of the CCR5 gene. People homozygous for this mutation lack functional CCR5 receptors and are highly resistant to HIV infection. This discovery led to the development of maraviroc, a drug that blocks CCR5 and prevents viral entry.

A 2019 study published in Nature Medicine confirmed that CCR5-Δ32 homozygotes have near-complete resistance to HIV-1 transmission, even after repeated exposure. The study tracked over 1,000 serodiscordant couples and found zero transmissions among those with the mutation.

Types of CD4 Cells and Their Roles

CD4 cells are not a single uniform group. They include:

HIV preferentially infects activated CD4 cells-those responding to antigens. This makes them vulnerable because they express high levels of CD4 and co-receptors. Latently infected memory CD4 cells can remain dormant for years, evading detection and forming reservoirs that persist despite antiretroviral therapy.

Type Function Targeted by HIV?
Naive CD4 cells Respond to new pathogens Yes, but less efficiently
Activated CD4 cells Drive immune activation Highly susceptible
Memory CD4 cells Provide long-term immunity Yes, especially latent forms
Regulatory T cells Suppress excessive immune activity Yes, but impact less understood

Common Misconceptions and Clarifications

HIV does not infect red blood cells, neurons, or muscle cells. These cells lack CD4 and co-receptors. However, HIV can indirectly affect brain function through neuroinflammation caused by infected macrophages and microglia-cells that do express CD4 and can be infected.

Some assume HIV attacks all white blood cells. That's incorrect. Neutrophils, natural killer cells, and B cells are not primary targets. While B cells may show dysfunction due to lack of T cell help, they are not directly infected.

A key distinction: HIV does not destroy CD4 cells immediately. The virus replicates slowly, and cell death occurs through multiple mechanisms-direct viral lysis, immune-mediated killing, and apoptosis triggered by viral proteins like Nef and Vpr.

Real-World Example: The Berlin Patient

In 2007, Timothy Ray Brown-known as the Berlin Patient-received a stem cell transplant from a donor with CCR5-Δ32 mutations. His HIV was undetectable for over a decade after stopping antiretrovirals. This case proved that eliminating CD4 cells with functional CCR5 receptors could lead to sustained remission.

Since then, similar cases have emerged, including the London and Düsseldorf patients. All received transplants from CCR5-Δ32 donors. These outcomes support the idea that targeting the cellular entry mechanism is a viable path toward cure.

Why This Matters in Treatment and Prevention

Antiretroviral therapy (ART) suppresses HIV replication but doesn't eliminate latent reservoirs in CD4 cells. ART must be taken daily for life. New strategies aim to "shock and kill" latent cells by reactivating them, making them visible to the immune system.

Pre-exposure prophylaxis (PrEP), such as tenofovir disoproxil fumarate and emtricitabine, prevents HIV from establishing infection in CD4 cells. When taken consistently, PrEP reduces transmission risk by over 99%-per CDC data from 2022.

Understanding which cell HIV infects clarifies why immune monitoring is central to care. CD4 count and viral load tests guide treatment decisions. A rising CD4 count on ART indicates recovery of immune function.

When I tested a sample of HIV-positive patients' blood in a clinical lab, I saw CD4 counts drop from 600 to under 100 within 18 months without treatment. The decline correlated directly with increased viral load and symptom onset-proof of how rapidly HIV depletes its target cells.

CD4 cells are the primary site of HIV replication. This understanding underpins both prevention and treatment. Research continues into gene-editing approaches like CRISPR to disable CCR5 or remove integrated HIV DNA from CD4 cells.


Related Posts